| Literature DB >> 35686436 |
Renee D Wegrzyn1, Grace D Appiah2, Robert Morfino1, Scott R Milford3, Allison Taylor Walker2, Ezra T Ernst3, William W Darrow3, Siyao Lisa Li1, Keith Robison1, Duncan MacCannell4, Dongjuan Dai1, Brintha P Girinathan1, Allison L Hicks1, Bryan Cosca1, Gabrielle Woronoff1, Alex M Plocik1, Birgitte B Simen1, Leah Moriarty2, Sarah Anne J Guagliardo2, Martin S Cetron2, Cindy R Friedman2.
Abstract
We enrolled arriving international air travelers in SARS-CoV-2 genomic surveillance, using molecular testing of pooled nasal swabs, and sequencing positive samples for viral sublineage. Traveler-based genomic surveillance provided early warning variant detection; we reported the first U.S. Omicron BA.2 and first BA.3 in North America, weeks before next reported detection.Entities:
Keywords: SARS-CoV-2; genomic surveillance; international travelers
Year: 2022 PMID： 35686436 PMCID： PMC9214179 DOI： 10.1093/cid/ciac461
Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 20.999